CD8a Antibody Super Bright 600 63-0088-42 from Thermo Fisher Scientific

Product Specs
ItemCD8a Antibody Super Bright 600
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number63-0088-42
Quantity100 Tests
ApplicationsFlow Cytometry
Concentration5 µL/Test
Conjugate/TagSuper Bright™ 600
FormatPBS with BSA and 0.09% sodium azide; pH 7.2
ReactivityHuman
TargetCD8a
IsotypeIgG1 kappa
CloneRPA-T8
HostMouse
NCBI Full Gene NameCD8 subunit beta, CD8 subunit alpha
NCBI Gene AliasesLY3, CD8alpha, CD8beta, Leu2, CD8B1, p32, LEU2, Ly-3, CD8, P37, LYT3
ClonalityMonoclonal
PurityAffinity chromatography
Antibody TypePrimary
Storage4°C, store in dark, DO NOT FREEZE!
Storage Temperature4° C, store in dark, DO NOT FREEZE!

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Protocol for isolation of tumor-derived extracellular vesicles and functional studies on human T cell subsetsSTAR protocolsJune 21, 2024Swatler J, Targońska A, Turos-Korgul L, Mosieniak G, Piwocka K.

(2) Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaquesNature communicationsApril 26, 2024Kaiser JA, Nelson CE, Liu X, Park HS, Matsuoka Y, Luongo C, Santos C, Ahlers LRH, Herbert R, Moore IN, et al.

(3) Immune response induced by standard and fractional doses of 17DD yellow fever vaccineNPJ vaccinesMarch 8, 2024Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, et al.

(4) TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathwaysThe Journal of experimental medicineDecember 4, 2023Chan W, Cao YM, Zhao X, Schrom EC, Jia D, Song J, Sibener LV, Dong S, Fernandes RA, Bradfield CJ, et al.

(5) Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell ImmunityInternational journal of molecular sciencesOctober 30, 2023Van Den Eeckhout B, Ballegeer M, De Clercq J, Burg E, Saelens X, Vandekerckhove L, Gerlo S.

(6) Prostate cancer cells synergistically defend against CD8(+) T cells by secreting exosomal PD-L1Cancer medicineAugust 1, 2023Li D, Zhou X, Xu W, Chen Y, Mu C, Zhao X, Yang T, Wang G, Wei L, Ma B.

(7) Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastomaOncology lettersJuly 1, 2023Zhang Y, Luo F, Dong K.

(8) Proteomics of immune cells from liver tumors reveals immunotherapy targetsCell GenomJune 14, 2023Canale FP, Neumann J, von Renesse J, Loggi E, Pecoraro M, Vogel I, Zoppi G, Antonini G, Wolf T, Jin W, et al.MEM-56),ThermoFisher,Cat#Q10069; RRID:AB_2556451 Human CD8 Super Bright 600 (clone RPA-T8),ThermoFisher,Cat#63-0088-42; RRID:AB_2637470 Human CD4 PE-Cy7 (clone SK3),BD Biosciences,Cat#557852; RRID:AB_396897 Human CD14

(9) Predominantly defective CD8(+) T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipientsJournal of translational medicineJune 8, 2023Taus E, Shino MY, Ibarrondo FJ, Hausner MA, Hofmann C, Yang OO.CD8-Super Bright 600, CD4 PE-Cy7, and Fixable Aqua viability dye (#62-0037-42, eBioscience, San Diego/CA; #63-0088-42, eBioscience, San Diego/CA; #25-0049-42, San Diego, CA; and #L34957, Invitrogen, Waltham, MA respectively),

(10) Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinomaCancer immunology, immunotherapy : CIIJune 1, 2023Lu T, Zhang J, Lu S, Yang F, Gan L, Wu X, Song H, Liu S, Xu C, Han D, et al.

(11) Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccinationFrontiers in immunologyJanuary 1, 2023Taus E, Hofmann C, Ibarrondo FJ, Gong LS, Hausner MA, Fulcher JA, Krogstad P, Kitchen SG, Ferbas KG, Tobin NH, et al.Bright 600, CD4 PE-Cy7, and Fixable Aqua viability dye (catalog #62-0037-42/eBioscience/San Diego/CA, #63-0088-42/eBioscience/San Diego/CA, #25-0049-42/San Diego/CA, and #L34957/Invitrogen/Waltham/MA respectively),

(12) PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cellsNature communicationsDecember 12, 2022Li Q, Zhang L, You W, Xu J, Dai J, Hua D, Zhang R, Yao F, Zhou S, Huang W, et al.

(13) VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasiseLifeDecember 9, 2022Li J, Huang D, Lei B, Huang J, Yang L, Nie M, Su S, Zhao Q, Wang Y.

(14) Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammationJCI insightSeptember 8, 2022Tchitchek N, Nguekap Tchoumba O, Pires G, Dandou S, Campagne J, Churlaud G, Fourcade G, Hoffmann TW, Strozzi F, Gaal C, et al.clone 17A2; catalog 48-0032-82), CD8 Super Bright 600 (Thermo Fisher Scientific; clone RPA-T8; catalog 63-0088-42), CD4 Horizon v500 (BD Biosciences; clone RM4-5; catalog 560782), CD45 PE-CF594 (BD Biosciences; clone

(15) Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid modelsFrontiers in oncologyJanuary 1, 2022Tan D, An J, Gong M, Wang H, Li H, Meng H, Zhang C, Zhao Y, Ge X, Shi C.

(16) Multipeptide stimulated PBMCs generate T(EM)/T(CM) for adoptive cell therapy in multiple myelomaOncotargetSeptember 28, 2021Vardam-Kaur T, Pathangey LB, McCormick DJ, Bergsagel PL, Cohen PA, Gendler SJ.

(17) Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomesNature communicationsMay 21, 2021Renner K, Schwittay T, Chaabane S, Gottschling J, Müller C, Tiefenböck C, Salewski JN, Winter F, Buchtler S, Balam S, et al.

(18) Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's diseaseNPJ Parkinson's diseaseMay 13, 2021Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, Beers DR, Lai EC, Appel SH.

(19) Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivoTheranosticsJanuary 1, 2021Zhong L, Shi W, Gan L, Liu X, Huo Y, Wu P, Zhang Z, Wu T, Peng H, Huang Y, et al.

(20) Changes of immune cells in patients with hepatocellular carcinoma treated by radiofrequency ablation and hepatectomy, a pilot studyOpen life sciencesJanuary 1, 2021Yu Z, Li G, Yu H, Asakawa T.

Be the First to Write a Review!

CD8a Antibody Super Bright 600

Flow

CD8a Antibody Super Bright 600

CD8a Antibody Super Bright 600 from Thermo Fisher Scientific

Thermo Fisher Scientific

Citations (42)

Reviews

CD8a Antibody Super Bright 600 from Thermo Fisher Scientific

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map